KeyBanc Starts Castle Biosciences (CSTL) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts CSTL Hot Sheet
Price: $34.50 +3.60%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 18
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 18
Join SI Premium – FREE
KeyBanc initiates coverage on Castle Biosciences (NASDAQ: CSTL) with a Overweight rating and a price target of $70.00.
For an analyst ratings summary and ratings history on Castle Biosciences click here. For more ratings news on Castle Biosciences click here.
Shares of Castle Biosciences closed at $51.70 yesterday.
You May Also Be Interested In
- Roth/MKM Starts Dianthus Therapeutics (DNTH) at Buy
- Freedom Broker Starts CVR Partners (UAN) at Hold
- Freedom Broker Starts LSB Industries (LXU) at Hold
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
